skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 3,715  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Black mamba venom peptides target acid-sensing ion channels to abolish pain
Material Type:
Article
Add to My Research

Black mamba venom peptides target acid-sensing ion channels to abolish pain

Nature (London), 2012-10, Vol.490 (7421), p.552-555 [Peer Reviewed Journal]

2015 INIST-CNRS ;COPYRIGHT 2012 Nature Publishing Group ;COPYRIGHT 2012 Nature Publishing Group ;Copyright Nature Publishing Group Oct 25, 2012 ;Attribution ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature11494 ;PMID: 23034652 ;CODEN: NATUAS

Full text available

2
Reply on new drugs against type 2 diabetes: important to gain experience and knowledge
Material Type:
Article
Add to My Research

Reply on new drugs against type 2 diabetes: important to gain experience and knowledge

Läkartidningen, 2008-04, Vol.105 (17-18), p.1310, 1312 [Peer Reviewed Journal]

ISSN: 0023-7205 ;EISSN: 1652-7518 ;PMID: 18561535

Full text available

3
Socker triggar våra belöningssystem. Sött frisätter opiater som sätter fart på sötsuget - insulin kan dämpa det
Material Type:
Article
Add to My Research

Socker triggar våra belöningssystem. Sött frisätter opiater som sätter fart på sötsuget - insulin kan dämpa det

Läkartidningen, 2005-05, Vol.102 (21), p.1620 [Peer Reviewed Journal]

ISSN: 0023-7205 ;EISSN: 1652-7518

Full text available

4
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial
Material Type:
Article
Add to My Research

Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial

Diabetes care, 2018-02, Vol.41 (2), p.258-266 [Peer Reviewed Journal]

2017 by the American Diabetes Association. ;Copyright American Diabetes Association Feb 1, 2018 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc17-0417 ;PMID: 29246950

Full text available

5
Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)
Material Type:
Article
Add to My Research

Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)

Diabetes care, 2014-08, Vol.37 (8), p.2159-2167 [Peer Reviewed Journal]

2015 INIST-CNRS ;2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Aug 2014 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc13-2760 ;PMID: 24879836 ;CODEN: DICAD2

Full text available

6
Tirzepatide Once Weekly for the Treatment of Obesity
Material Type:
Article
Add to My Research

Tirzepatide Once Weekly for the Treatment of Obesity

The New England journal of medicine, 2022-07, Vol.387 (3), p.205-216 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2206038 ;PMID: 35658024

Full text available

7
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Material Type:
Article
Add to My Research

Once-Weekly Semaglutide in Adults with Overweight or Obesity

The New England journal of medicine, 2021-03, Vol.384 (11), p.989-1002 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2032183 ;PMID: 33567185

Full text available

8
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
Material Type:
Article
Add to My Research

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

The New England journal of medicine, 2021-03, Vol.384 (12), p.1113-1124 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2028395 ;PMID: 33185364

Full text available

9
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Material Type:
Article
Add to My Research

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2017-10, Vol.390 (10103), p.1664-1675 [Peer Reviewed Journal]

2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 7, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)31585-4 ;PMID: 28781108

Full text available

10
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
Material Type:
Article
Add to My Research

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

The New England journal of medicine, 2021-08, Vol.385 (6), p.503-515 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2107519 ;PMID: 34170647

Full text available

11
Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model
Material Type:
Article
Add to My Research

Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model

Nature neuroscience, 2019-05, Vol.22 (5), p.719-728 [Peer Reviewed Journal]

2019© The Author(s), under exclusive licence to Springer Nature America, Inc. 2019 ;ISSN: 1097-6256 ;EISSN: 1546-1726 ;DOI: 10.1038/s41593-019-0372-9 ;PMID: 30936558

Full text available

12
Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues
Material Type:
Article
Add to My Research

Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues

Advanced drug delivery reviews, 2016-11, Vol.106, p.256 [Peer Reviewed Journal]

ISSN: 1872-8294 ;ISSN: 0169-409X ;EISSN: 1872-8294 ;DOI: 10.1016/j.addr.2016.07.007

Digital Resources/Online E-Resources

13
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Material Type:
Article
Add to My Research

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

The New England journal of medicine, 2019-08, Vol.381 (9), p.841-851 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1901118 ;PMID: 31185157

Full text available

14
Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial
Material Type:
Article
Add to My Research

Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial

The Lancet (British edition), 2019-07, Vol.394 (10192), p.39-50 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31271-1 ;PMID: 31186120

Full text available

15
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Material Type:
Article
Add to My Research

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

The New England journal of medicine, 2017-09, Vol.377 (13), p.1228-1239 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1612917 ;PMID: 28910237

Full text available

16
Cationic Cell-Penetrating Peptides Are Potent Furin Inhibitors
Material Type:
Article
Add to My Research

Cationic Cell-Penetrating Peptides Are Potent Furin Inhibitors

PloS one, 2015-06, Vol.10 (6), p.e0130417-e0130417 [Peer Reviewed Journal]

2015 Ramos-Molina et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Ramos-Molina et al 2015 Ramos-Molina et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0130417 ;PMID: 26110264

Full text available

17
Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes
Material Type:
Article
Add to My Research

Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes

The New England journal of medicine, 2009-05, Vol.360 (21), p.2176-2190 [Peer Reviewed Journal]

Copyright © 2009 Massachusetts Medical Society. All rights reserved. ;2009 INIST-CNRS ;2009 Massachusetts Medical Society ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa0901316 ;PMID: 19332455 ;CODEN: NEJMAG

Full text available

18
PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes
Material Type:
Article
Add to My Research

PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes

Diabetes care, 2019-09, Vol.42 (9), p.1724-1732 [Peer Reviewed Journal]

2019 by the American Diabetes Association. ;Copyright American Diabetes Association Sep 1, 2019 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc19-0749 ;PMID: 31186300

Full text available

19
Effects of Doxorubicin on the Liquid-Liquid Phase Change Properties of Elastin-Like Polypeptides
Material Type:
Article
Add to My Research

Effects of Doxorubicin on the Liquid-Liquid Phase Change Properties of Elastin-Like Polypeptides

Biophysical journal, 2018-10, Vol.115 (8), p.1431-1444 [Peer Reviewed Journal]

2018 Biophysical Society ;Copyright © 2018 Biophysical Society. Published by Elsevier Inc. All rights reserved. ;2018 Biophysical Society. 2018 Biophysical Society ;ISSN: 0006-3495 ;EISSN: 1542-0086 ;DOI: 10.1016/j.bpj.2018.09.006 ;PMID: 30292393

Full text available

20
Designing antimicrobial peptides: form follows function
Material Type:
Article
Add to My Research

Designing antimicrobial peptides: form follows function

Nature reviews. Drug discovery, 2012-01, Vol.11 (1), p.37-51 [Peer Reviewed Journal]

COPYRIGHT 2012 Nature Publishing Group ;Copyright Nature Publishing Group Jan 2012 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd3591 ;PMID: 22173434

Full text available

Results 1 - 20 of 3,715  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (3,547)

Refine My Results

Creation Date 

From To
  1. Before 1977  (79)
  2. 1977 To 1987  (103)
  3. 1988 To 1998  (599)
  4. 1999 To 2010  (1,287)
  5. After 2010  (1,648)
  6. More options open sub menu

Language 

  1. English  (3,676)
  2. Japanese  (564)
  3. German  (21)
  4. French  (8)
  5. Russian  (7)
  6. Spanish  (6)
  7. Dutch  (5)
  8. Swedish  (4)
  9. Portuguese  (4)
  10. Polish  (3)
  11. Italian  (1)
  12. Norwegian  (1)
  13. Chinese  (1)
  14. More options open sub menu

Searching Remote Databases, Please Wait